117 related articles for article (PubMed ID: 31357175)
1. Elevated surface-bound complement FH alters the function of platelets and monocytes in FHR1/3 null healthy individuals.
Bhasym A; Bhakuni T; Guchhait P
Blood Cells Mol Dis; 2019 Nov; 79():102349. PubMed ID: 31357175
[TBL] [Abstract][Full Text] [Related]
2. Altered Peripheral Blood Leucocyte Phenotype and Responses in Healthy Individuals with Homozygous Deletion of FHR1 and FHR3 Genes.
Bhasym A; Gurjar BS; Prabhu S; Puraswani M; Khandelwal P; Saini H; Saini S; Chatterjee P; Bal V; George A; Coshic P; Patidar G; Hari P; Sinha A; Bagga A; Rath S; Guchhait P
J Clin Immunol; 2019 Apr; 39(3):336-345. PubMed ID: 30945073
[TBL] [Abstract][Full Text] [Related]
3. Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation.
Papp A; Papp K; Uzonyi B; Cserhalmi M; Csincsi ÁI; Szabó Z; Bánlaki Z; Ermert D; Prohászka Z; Erdei A; Ferreira VP; Blom AM; Józsi M
Front Immunol; 2022; 13():845953. PubMed ID: 35392081
[TBL] [Abstract][Full Text] [Related]
4. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
Front Immunol; 2021; 12():676662. PubMed ID: 34489931
[TBL] [Abstract][Full Text] [Related]
5. Atypical Hemolytic Uremic Syndrome-Associated FHR1 Isoform FHR1*B Enhances Complement Activation and Inflammation.
Xu B; Kang Y; Du Y; Guo W; Zhu L; Zhang H
Front Immunol; 2022; 13():755694. PubMed ID: 35126388
[TBL] [Abstract][Full Text] [Related]
6. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
Front Immunol; 2019; 10():853. PubMed ID: 31118930
[TBL] [Abstract][Full Text] [Related]
7. Complement Factor H Family Proteins Modulate Monocyte and Neutrophil Granulocyte Functions.
Kárpáti É; Kremlitzka M; Sándor N; Hajnal D; Schneider AE; Józsi M
Front Immunol; 2021; 12():660852. PubMed ID: 34671340
[TBL] [Abstract][Full Text] [Related]
8. Complement Factor H related protein 1 and immune inflammatory disorders.
Li X; Zong J; Si S
Mol Immunol; 2022 May; 145():43-49. PubMed ID: 35279539
[TBL] [Abstract][Full Text] [Related]
9. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.
Tortajada A; Yébenes H; Abarrategui-Garrido C; Anter J; García-Fernández JM; Martínez-Barricarte R; Alba-Domínguez M; Malik TH; Bedoya R; Cabrera Pérez R; López Trascasa M; Pickering MC; Harris CL; Sánchez-Corral P; Llorca O; Rodríguez de Córdoba S
J Clin Invest; 2013 Jun; 123(6):2434-46. PubMed ID: 23728178
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization.
Kárpáti É; Papp A; Schneider AE; Hajnal D; Cserhalmi M; Csincsi ÁI; Uzonyi B; Józsi M
Front Immunol; 2020; 11():1297. PubMed ID: 32765490
[TBL] [Abstract][Full Text] [Related]
11. Characterization of genetic predisposition and autoantibody profile in atypical haemolytic-uraemic syndrome.
Gurjar BS; Manikanta Sriharsha T; Bhasym A; Prabhu S; Puraswani M; Khandelwal P; Saini H; Saini S; Verma AK; Chatterjee P; Guchhait P; Bal V; George A; Rath S; Sahu A; Sharma A; Hari P; Sinha A; Bagga A
Immunology; 2018 Feb; 154(4):663-72. PubMed ID: 29485195
[TBL] [Abstract][Full Text] [Related]
12. Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies.
Irmscher S; Brix SR; Zipfel SLH; Halder LD; Mutlutürk S; Wulf S; Girdauskas E; Reichenspurner H; Stahl RAK; Jungnickel B; Wiech T; Zipfel PF; Skerka C
Nat Commun; 2019 Jul; 10(1):2961. PubMed ID: 31273197
[TBL] [Abstract][Full Text] [Related]
13. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
Tortajada A; Gutiérrez E; Goicoechea de Jorge E; Anter J; Segarra A; Espinosa M; Blasco M; Roman E; Marco H; Quintana LF; Gutiérrez J; Pinto S; Lopez-Trascasa M; Praga M; Rodriguez de Córdoba S
Kidney Int; 2017 Oct; 92(4):953-963. PubMed ID: 28637589
[TBL] [Abstract][Full Text] [Related]
14. Structural modelling of human complement FHR1 and two of its synthetic derivatives provides insight into their in-vivo functions.
Ruiz-Molina N; Parsons J; Decker EL; Reski R
Comput Struct Biotechnol J; 2023; 21():1473-1486. PubMed ID: 36851916
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
[TBL] [Abstract][Full Text] [Related]
16. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
[TBL] [Abstract][Full Text] [Related]
17. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
18. FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.
Csincsi ÁI; Szabó Z; Bánlaki Z; Uzonyi B; Cserhalmi M; Kárpáti É; Tortajada A; Caesar JJE; Prohászka Z; Jokiranta TS; Lea SM; Rodríguez de Córdoba S; Józsi M
J Immunol; 2017 Jul; 199(1):292-303. PubMed ID: 28533443
[TBL] [Abstract][Full Text] [Related]
19. Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP.
Castiblanco-Valencia MM; Fraga TR; Silva LB; Monaris D; Abreu PA; Strobel S; Józsi M; Isaac L; Barbosa AS
J Infect Dis; 2012 Mar; 205(6):995-1004. PubMed ID: 22291192
[TBL] [Abstract][Full Text] [Related]
20. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
Ståhl AL; Vaziri-Sani F; Heinen S; Kristoffersson AC; Gydell KH; Raafat R; Gutierrez A; Beringer O; Zipfel PF; Karpman D
Blood; 2008 Jun; 111(11):5307-15. PubMed ID: 18268093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
